Gurugram, India – A developer of novel biotherapeutic and vaccine candidates, Premas Biotech, announced the development of an oral Covid-19 vaccine shown to be effective after a single dose.

Premas, along with Oramed Pharmaceuticals Inc. and other shareholders, have partnered to form Oravax Medical Inc., an entity that would receive exclusive licences to develop oral Covid-19 vaccines, reported businesswire.com on Mar 19.